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Abstract
As the results of investigating the antigenicities of various fractions from the membrane sys-
tems of cancer cells, it has been found that the remarkable cancer-specific antigenicity exists in
cancer cell mitochondria. With a particular reference to this antigenicity of cancer cell mitochon-
dria, the antigenicities of the mitochondria of various kinds of rat ascites tumors and those of
tumor-bearing rat liver mitochondria have been compared with those of normal rat liver mitochon-
dria. In addition, it has been demonstrated that a strong tumor antitransplantability is induced
when the recipient rat is immunized with the tumor cell mitochondria. In order to support these
experimental facts, enzymatic activities of cancer cell mitochondria have been investigated also
biochemically after treating the mitochondria with the antiserum to these mitochondria. 1. The
most remarkable cancer specific antigenicity exists in mitochondria among the membrane systems
of cancer cells. This cancer mitochondria-specific cancer antigenicity is common to all the ascites
tumor mitochondria used here. 2. The original tissue- or organ-specific antigenicities diminish or
disappear at the carcinogenic transformation of cells. 3. The tumor-bearing-organ specific anti-
genicity appears in the organs of animals bearing tumor. 4. The tumor antitransplantability is
acquired when rats are immunized with these tumor cell mitochondria. 5. The inhibition of mi-
tochondrial ATP·ase and respiratory activities is observed when the cancer cell mitochondria are
treated with the anti. serum to the mitochondria.
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The literature is replete with works on specific tumor antigen existing
itself in tumors such as human cancers, spontaneous tumors of animals
and artificial neoplasma induced by chemical carcinogens or viruses. At
the same time, comparative studies on the antigenicity of organs or tissues
of tumor"bearing animals and that of the same organs or tissues of normal
animals were carried out from the aspects of immuno-specificity of the
tumor-bearing body. Since it has become possible to conduct comparative
studies on the antigenicity of individual fractions from the membrane
systems of cells at subcellular level owing to the advent of ultracentrifuga-
tion, numerous reports have appeared, suggesting the existence of specific
cancer antigenicity in cancer cell mitochondria (1-8). Subsequently many
investigators (9-16) have stated about the changes of organ or tissue
specific antigenicity in tumor-bearing animals.
The immunochemical analysis of membrane fractions from cancer
cells conducted by this author (17) has revealed that the highest cancer-
specific antigenicity exists in mitochondria in the membrane systems of
AH 130 rat ascites hepatom~ cells. The present experiments were con-
ducted with the purpose to compare the specific antigenicity in the mito-
chondria of various kinds of rat ascites tumors induced by various carcino-
gens and of tumor-bearing rat liver mitochondria with that of normal cell
mitochondria. The results indicated that the mitochondria of every rat
ascites tumor induced by chemical carcinogens have specific cancer anti-
genicity, and that this antigenicity of cancer cell mitochondria is common
to various rat ascites tumors induced by various chemical carcinogens. In
addition, a study was made to clarify whether there is tumor anti-trans.
* The outline of the present report was presented at the 26th Annual Meeting of the Japanese
Cancer Association (18). This work was supported by research g;ants of Japanese Ministry
of Education.
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plantability in the rats immunized with cancer cell mitochondria.
MATERIALS AND METHODS
All rats used were inbred Donryu strain. The cancer strains used were
rat ascites hepatoma (AH130, AH225A, and AH66F) and ascites form Yoshida
sarcoma. AH225A, AH66F and Yoshida sarcoma were obtained through the
courtesy of Drs. T. YOSHIDA and H. SATO in Sasaki Institute, 2-2 Kanda-
Surugadai, Chiyoda-ku, Tokyo, Japan.
Isolation of mitochondria: Tumor cell mitochondria, and normal and tumor-
bearing rat liver mitochondria were isolated by the modification of the method
of HOGEBOOM (19).
a) Tumor cell mitochondria (those of AH130, AH225A, AH66F and Yoshida
sarcoma): Rat ascites tumor cells were harvested one week after the trans-
plantation of ascites tumor cells to rat. In this instance, Yoshida sarcoma
cells were harvested five days after the transplantation of tumor cells to rat.
The ascites fluid was centrifuged at 800 x g for 10 minutes, and by removing
the supernatant, the residue was washed repeatedly by centrifugation with
0.25 M sucrose solution containing 0.1 mM EDTA and 10 mM Tris-HCl, pH
7.6. The washed ascites tumor cells (50 g wet weight per 100 ml) were sus-
pended in 0.25 M sucrose solution containing 0.1 mM EDTA and 10 mM
Tris-HCl, pH 7.6, and then 10 volumes of cold one mM NaHCO I (pH 7.6)
solution was added and incubated for 20 minutes at O°C before homogeniza-
tion. A tightly-fitted teflon pestle was rotated and the glass tube was moved
up and down over the pestle. Tris-bufferd one M sucrose solution (pH 7.6)
was added to this suspension to make the final concentration 0.25 M. This
homogenate was centrifuged at 700 x g for 10 minutes. The residue as the
nuclear fraction, was discarded and the supernatant was layered on an equal
volume of 0.34 M sucrose solution containing 0.1 mM EDTA and 10 mM
Trisl-HCl, pH 7.6, and centrifuged at 800xg for 10 minutes. The upper layer
was transferred to a centrifuge tube with a pipette, and centrifuged at 5,000
x g for 10 minutes. After discarding the supernatant, the residue (mitochon-
dria pellet) was washed twice with 0.25 M sucrose solution containing 10 mM
Tris-HCl, pH 7.6 by centrifugation at 7,000 x g for 10 minutes.
b) Normal and tumor-bearing rat liver mitochondria: Normal and tumor-bearing
rat livers were assembled, minced, and suspended in 0.25 M sucrose solution
containing 0.1 mM EDTA and 10 mM Tris-HCl, pH 7.6 at aoc before centri-
fugation. A tightly-fitted teflon pestle of the homogenizer was rotated, and
the glass tube was moved up and down over the pestle. The homogenate was
centrifuged at 700 x g for 10 minutes. By discarding the residue, the super-
natant was layered on an equal volume of 0.34 M sucrose solution containing
0.1 mM EDTA and 10 mM Tris-HCl, pH 7.6, and centrifuged at 800 x g
for 10 minutes, The upper layer was transferred to a centrifuge tube with a
pipette, and centrifuged at 7,000 x g for 10 minutes. By removing the super-
natant, the residue (mitochondria pellet) was washed twice with 0.25 M
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sucrose solution containing 10 mM Tris-HCI, pH 7.6, by centrifugation at
9,000 x g for 10 minutes. The other fractions were prepared by the same method
of previous report (17). All the preparations were done at 0°-4°C.
White adult male rabbits weighing about 2 to 3 kg and young rats weighing
about 150 to 200 g were used for the purpose of immunization.
Homogenous and heterogenous immunization were the procedures to
immunize animals.
The immunizing procedures: Subcutaneous inoculation method and intra-
peritoneal inoculation method were used.
a) Subcutaneous inoculation method; Each rabbit received several injections
of 0.5 to 1.0 ml volumes of 30 mg of antigenic proteins incorporated into 3 ml
of Freunds' complete adjuvant (Difco Freunds' Adjuvant Complete) three times
subcutaneously at the interval of once a week at the middle area between
both shoulder blades, and each rat received once a week several injections of
0.5 to 1.0 ml volumes of 0.25 to 0.5 mg of antigenic proteins incorporated
into 3 ml of Freunds' complete adjuvant at the axilla and side neck.
b) Intraperitoneal inoculation method; The modified method of MUNOZ (20)
was used for this experiment. Each rat was given a series of three intraperito-
neal injections of antigens. Each injection consisted of one ml of adjuvant
complete and 250 to 500 micrograms of antigenic protein or 250 to 500 micro-
grams protein as a saline suspension. Immunizations were done at the interval
of once a week.
Serum preparation method: Rabbit blood samples were collected from the
auricular vein on the 14th day after the last inoculation, and these samples
were allowed to clot at 20°C for one hour. Then the serum was removed from
erythrocytes, and heated at 56°C for 30 minutes to inactivate complement.
Each serum titer was measured at once, and the rabbits of low titer serum
were boostered. The serum so collected was added each time with 0.01 % of
methiolate, and stored at -- 20°C until used. The rats immunized intraperito.
neally were transplanted with fresh ascites tumor cells (2 x 107) 14 to 20 days
after the last inoculation, and tumor anti-transplantability in the immunized
rats was observed. The serum of those rats that had a powerful anti trans-
plantability was used for the biochemical experiments.
Methods for the determination of antigen-antibod)! reactions: Ouchterlony agar
double diffusion method and immunoelectrophoresis in agar gel were used for
the determination of antigen-antibody reactions. Difco Special Noble agar
was used for double diffusion.
For the immunodiffusion in agar gel, a solution of 1.5 % agar in physiolo-
gical saline containing 0.01 % merthiolate was prepared. This agar solution
was poured into the disk about 9 cm in diameter, and allowed to harden to
give a layer 3 to 5 mm thick. A central well and six circumferential wells
were punched out in such a way that each surrounding well was 6 mm apart
from the central well, making the center to center distance of central well to
each surrounding well 20 mm (Macro Ouchterlony Method (21 )).
An antiserum sample was poured into the central well and each test antigen
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was poured into 6 surrounding wells. Before testing for those fractions proved
to be insoluble, each test antigen was dissolved with one 96 sodium deoxy-
cholate to give solubility and diffusibility in agar gel. Protein concentration
of each fraction was about 2 to 3 mg protein/ml. In agar immunoelectro.
phoresis (22), agar powder was added to distilled water to make the final
concentration 496. This suspension was heated to dissolve agar, then cooled,
and this agar gel was cut about one cm'l in volume, and washed in a running
water for about 2 days, then dialysed 3 days or more against deionized water.
Then, this purified 4 96 agar gel of one cm3 was dissolved into 0.1 M veronal
buffer solution to make the final concentration 1.0 %. This agar solution
poured on the glass plate with a frame of 10 x 7.5 cm, then allowed to har-
den to give a layer 2 to 3 mm thick. This agar plate was divided into three
small agar plate of 2 cm width by cutting four troughs of 3 mm width in an
equal distance apart. A well of 4 mm in diameter was cut at the center of
each small agar plate as Fig. 1. In this well was poured the test antigen or
antiserum and the electrophoresis was done. This is the macro-immunoelectro.
phoresis. The purification method of agar used in this experiment was the
fil te
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Fig. 1 Illustration of agar plate used for immunoelectrophoresis
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modification of the method of TAKAYANAGI (23). In electrophoresis, the buffer
solution used was 0.1 M veronal solution, and the electrode solution was O. I
M HCI solution. The condition of electrophoresis was in 260 V, 20 mA, for
six hours. After the electrophoresis, the antisera were poured into the troughs
at once, then the Ouchterlony reactions were begun. The samples were set at
room temperature for one hour, then changing the temperature of 0° to 4°C
and left overnight. Twenty-four hours, 48 hours, and 72 hours after the start
of the test, they were observed and photographed. The photographs for the
comparison were used at 48 hours in Ouchterlony diffusion and at 72 hours in
immunoelectrophoresis.
The observations of tumor-antitransplantability: As the facts supporting the anti-
transplantability to tumor in immunized rats, the phenomenon of the tumor
rejection in host to transplanted tumors appeared, when the fresh ascites tumor
cells were inoculated intraperitoneally to immunized rats, and the changes in
cancer cell mitochondrial ATP-ase activities when the fresh cancer cell mito-
chondria were made to react with the rat sera immunized with cancer cell
mitochondria, and the changes in cell respiration itself when cancer cells were
incubated in the rat antisera immunized with cancer cell mitochondria.
ATP-ase activities were expressed in mil moles of released Pi/mg of pro-
tein/minute at pH 7.6, measuring released Pi after the reaction by the method
of TAKAHASHI (24). Oxygen consumption of cancer cells was measured by
an oxymeter with rotating platinum electrode (25) in the presence of sodium
succinate as the substrate.
RESULTS
The cross-matchings in agar gel: From the cross.matching in agar
gel diffusion of the rabbit-antiserum to AH130 rat ascites hepatoma cell
mitochondria (anti-HMt serum) against various kinds of rat ascites tumor
mitochondria (mitochondria of AH 130, AH225A, AH66F and Yoshida
sarcoma), rat liver mitochondria, and tumor-bearing rat liver mitochondria,
all kinds of tumor mitochondria including Yoshida sarcoma mitochondria
reacted to this serum , forming a sharp precipitin band remarka bly. Mito-
chondria of three different kinds of ascites hepatomas (AH 130, AH225A
and AH66F) and AHl30.bearing rat liver mitochondria formed another
sharp precipitin band just as rat liver mitochondria, suggesting it to be
due to a tissue or organ specific mitochondrial antigen. In Yoshida
sarcoma mitochondria, however, the common antigenicity to rat liver
mitochondria was absent (Fig. 2, Photo. 1).
In the cross-matching in agar gel diffusioi1 of the rabbit-antiserum to
AH225A rat ascites hepatoma cell mitochondria (anti-AMt serum) against
various kinds of rat ascites tumor cell mitochondria (mitochondria of AH
130, AH225A, AH66F and Yoshida sarcoma), rat liver mitochondria,
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Fig. 2 The results obtained by Ouchterlony double diffu-
sion test. Central well contains the rabbit-antiserum to AHl30
rat ascites hepatoma mitochondria. Surrounding wells contain
variolAs antigens as illustrated below. HMt: AHl30 hepatoma
mitochondria. AMt: AH225A hepatoma mitochondria. FMt:
AH66F hepatoma mitochondria. YMt: Yoshida sarcoma mito-
chondria. NRM: rat liver mitochondria. HBM: AHl30 bear-
ing-rat liver mitochondria.
and tumor-bearing rat liver mitochondria, all the tumor mitochondria
also reacted against anti-AMt serum, forming a sharp precipitin band
remarkably. However, in this instance, it is not clear whether or not the
common antigenicity to the liver mitochondria was present in cancer cell
mitochondria (Fig. 3, Photo. 2).
Fig. 3 The results obtained by Ouchterlony double diffu-
sion test. Central well contains the rabbit-antiserum to AH225A
rat ascites hepatoma mitochondria. Surrounding wells contain
various antigens as illustrated below. HMt: AHl30 rat ascites
hepatoma mitochondria. AMt: AH225A rat ascites hepatoma
mitochondria. FMt: AH66F rat ascites hepatoma mitochondria.
YMt: Yoshida sarcoma mitochondria. NRM: rat liver mito-
chondria. ABM: AH225A hepaton,a bearing-rat liver mitochon-
dria.
In the case of cross-matching the rabbit-antiserum to AH66F rat
ascites hepatoma cell mitochondria (anti-F1-1t serum) in agar gel diffusion
against various kinds of rat ascites tumor cell mitochondria (mitochondria
of AH130, AH225A, AH66F and YOSHIDA sarcoma), rat liver mitochon-
dria and human liver mitochondria, all the tumor cell mitochondria
reacted on this antiserum, forming a sharp precipitin band remarkably.
The common antigenicity to rat liver mitochondria was traced in three
different kinds of rat ascites hepatoma cell mitochondria except Yoshida
sarcoma mitochondria as shown in Fig. 2 (Fig. 4).
Fig. 4 The results obtained by Ouchterlony double diffusion
test. Central well contains the rabbit-antiserum to AH66F rat
ascites hepatoma mitochondria. Surrounding wells contain various
antigens as illustrated below. HMt: AH130 rat ascites hepatoma
mitochondria. AMt: AH225A rat ascites hepatoma mitochondria.
FMt: AH66F rat ascites hepatoma mitochondria. YMt: Yoshida
sarcoma mitochondria. NRM: rat liver mitochondria. Mt: human
liver mitochondria.
From the results of the cross·matching vanous rat ascites hepatoma
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cell mitochondria in agar gel diffusion against each antiserum after the
electrophoresis, it is clear that there surely existed the immuno-specificity
in the mitochondria of these four different kinds of rat ascites tumors,
and this immuno-specificity was common to all the tumor cell mitochon-
dria. Moreover, this immunospecificity was tumor mitochondria specific.
One of these specific antigenicities exists in a 1 globulin position, and the
other thought to be common to all the cancer cell mitochondria, in (12
globulin position immuno-electrophoretically. Further, it was shown that
rat liver mitochondria had 8 organ-specific mitochondrial antigens and
such antigenicity diminished at the stage of carcinogenic transformation
of cells, and on the contrary, specific cancer antigenicities of cancer cell
mitochondria were potentiated remarkably (Fig. 5, Photo. 3).
<+) anti-HMtserum
anti-AMt serum
j ~= ::92af0-~1
a~ti-NH1d serum
e:-~I
anti-FMt serum
Fig. 5 The results of the immunoelectrophoresis.
The condition of electrophoresis in agar gel was in 260 V,
20 rnA, at O°C, for 6 hours. After that, the antisera
were poured into the troughs at once, then the Ouch-
terlony reactions were begun. HMt: AH130 hepatoma
mitochondria. AMt: AH225A hepatoma mitochondria.
NRM: rat liver mitochondria. FMt: AH66F hepatoma
mitochondria.
In the case of cross-matching in agar gel diffusion of the rabbit.anti-
serum to AHl30 rat ascites hepatoma-bearing rat liver mitochondria (anti-
HBM serum) against various kinds of tumor-bearing rat liver mitochondria
(liver cell mitochondria of the rat bearing AH130, AH225A, AH66F, and
Yoshida sercoma), rat liver mitochondria, and human liver mitochondria,
these kinds of tumor-bearing rat liver mitochondria reacted on this anti-
serum, forming precipitin bands thought to be specific to tumor-bearing
rat liver mitochondria. It is clear that AHl30-bearing rat liver mitochon.
dria have the antigenicities common to rat liver mitochondria, and that
the specific antigenicity also exists in AH 130.bearing rat liver mitochon-
dria (Fig. 6).
8
Fig. 6 The results obtained by Ouchterlony double diffusion
test. Central well contains the rabbit-antiserum to AH 130 bear-
ing-rat liver mitochondria. Surrounding wells contain various
antigens as follows: HBM: AH 130 bearing-rat liver mitochon-
dria. ABM: AH225A bearing-rat liver mitochondria. FBM:
AH66F bearing-rat liver mitochondria. YBM: Yoshida sarcoma
bearing-rat liver mitochondria. NRM: rat liver mitochondria.
Mt: human liver mitochondria.
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In the cross-matching in agar gel diffusion of the rabbit-antiserum to
AH225A rat ascites hepatoma-bearing rat liver mitochondria (anti·ABM
serum) against various tumor-bearing rat liver mitochondria (Fig. 7,
Photo. 4), in the cross-matching of the rabbit-antiserum to AH66F rat
ascites hepatoma. bearing rat liver mitochondria (anti-FBM serum) against
various kinds of mitochondria (Fig. 8, Photo. 5), and in the cross-match-
ing of the rabbit·antiserum to Yoshida sarcoma.bearing rat liver mitochon-
dria (anti-YBM serum) against various kinds of mitochondria (Fig. 9), ithas been demonstrated that each tumor-bearing rat liver mitochondria
have the antigenicities common to rat liver mitochondria, and that in
addition to this, there surely exists specific antigenicity common in indivi-dual tumor-bearing rat liver mitochondria. This specific antigenicity
common in tumor-bearing rat liver mitochondria was not detected in can-
cer cell mitochondria nor in rat liver mitochondria.
8
8
8
Fig. 7 The results obtained by Ouchterlony double diffu-
sion test. Central well contains the rabbit-antiserum to AH225A
hepatoma bearing-rat liver mitochondria. Surrounding wells
contain various antigens as follows: HBM: AHl30 bearing-rat
liver mitochondria. ABM: AH225A bearing-rat liver mitochon-
dria. FBM: AH66F bearing-rat liver mitochondria. YBM:
Yoshida sarcoma bearing-rat liver mitochondria. NRM: rat
liver mitochondria. Mt: human liver mitochondria.
Fig. 8 The res'Jlts obtained by Ouchterlony double diffu-
sion test. Central well contains the rabbit-antisernm to AH66F
hepatoma .bearing-rat liver mitocl:ondria. S~rrounding wells
contain various antigens as follows: HBM: AH 130 bearing-rat
liver mitochondria. ABM: AH225A bearin5-rat liver mitochon-
dria. FBM: AH66F bearing-rat liver mitochondria. YBM:
Yoshida sarcoma bearing-rat liver mitochondria. NRM: rat
liver mitochondria. Mt: human liver mttochondria.
Fig. 9 The results obtained by Ouchterlony double diffu-
sion test. Central well contains the rabbit-antiserum to Yoshida
sarcoma bearing-rat liver mitochondria. Surrounding wells
contain varions antigens as follows: HBM: AH 130 bearin~-rat
liver mitochondria. ABM: AH225A bearing-rat liver mitochon-
dria. FBM: AH 66 F bearing-rat liver mitochondria. YBM:
Yoshida sarcoma bearing-rat liver mitochondria NRM: rat liver
mitochondria. Mt: human liver mitochondria.
Immunoelectrophoretical analysis indicates that in tumor-bearing rat
liver mitochondria the organ specific mitochondrial antigenicities were
8
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slightly diminished and a specific antigenicity of tumor-bearing rat liver
mitochondria appeared in al globulin position (Figs. 10, 11, Photo. 6).
anti-HBM serum
(+) anti-Nk.ld serum ()~";~-l
anti-ABM serum
~i
anti-Nk.ld serum
(+) anti-YBW serum (-
~~..........,< ---'"
anti-.utt serum
anti HBM serum
Fig. 10 The results of the immunoelectrophoresis.
The condition of electrophoresis in agar gel was in 260V,
20mA, at O°C, for 6 hours. After that, the antisera
were poured into the troughs at once, then the
Ouchterlony reactions were begun. NRM: rat liver
mitochondria. ABM: AH225A hepatoma-bearing rat
liver mitochondria. FBM: AH66F hepatoma bearing-
rat liver mitochondria.
Fig. 11 The results of the immunoelectrophoresis.
The condition of electrophoresis in agar gel was in
260V, 20mA, at O°C, for 6 hours. After that, the
antisera were poured into the troughs at once, then the
Ouchterlony reactions were begun. YBM: Yoshida
sarcoma bearing-rat liver mitochondria. HBM: AHl30
hepatoma bearing-rat liver mitochondria. AMt: AH-
225A hepatoma mitochondria. Mt: human liver mito-
chondria.
The cross-matchings in agar gel of the rabbit-antiserum to rat liver
mitochondria (anti-NRM serum) against various kinds of tumor mitochon-
dria (the mitochondria of AH130, AH225A, AH66F and Yoshida sarcoma),
have demonstrated that the organ specific mitochond.rial antigenicities
common to rat liver mitochondria are remarkably diminished in tumor
cell mitochondria (Fig. 12, Photo. 7).
8
Fig. 12 The results obtained by Ouchterlony double diffu-
sion teflt. Central well contains the rabbit-antiserum to rat liver
mitochondria. Surrounding wells contain variot:s antigens as
illustrated below. HMt: AH130 rat ascites hepatoma mitochon-
dria. AMt: AH225A rat ascites hepatoma mitochondria. FMt:
AH66F rat ascites hepatoma mitochondria. YMt: Yoshida
sarcoma mitochondria. NMT: rat liver mitochondria. Fz: rat
liver microsomes.
As the rabbit-antiserum to AH 130 rat ascites hepatoma cell mitochon-
dria absorbed with rat liver mitochondria respond remarkably to those
fOUf different kinds of tumor mitochondria, forming a sharp precipitin
band (Fig. 13, Photo. 8), it is obvious that the tumor mitochondria-
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specific antigenicity appears at the stage of carcinogenic transformation
of cells.
Fig. 13 The results obtained by Ouchterlony double diffu-
sion test. Central well contains the rabbit-anti-AH130 cell mito-
chondria serum observed with rat liver mitochondria. Surround-
ing wells contain various antigens as illustrated below. HMt:
AH130 rat ascites hepatoma mitochondria. AMt: AH225A rat
ascites hepatoma mitochondria. FMt: AH66F rat ascites hepa-
toma mitochondria. YMt: Yoshida sarcoma mitochondria.
NRM: rat liver mitochondria. ABM: AH225A bearing-rat liver
mitochondria.
In the similar cross-matchings, it is known that the organ specific
mitochondrial antigenicities common to rat liver mitochondria do not
diminish so remarkably in the tumor-bearing rat liver mitochondria (Fig.
14, Photo. 9). All the antigen-antibody reactions in these instances take
place immunoelectrophoretically in r-globulin region (Fig. 15, Photo. 10).
Fig. 14 The results obtained by Ouchterlony double diffu-
sion test. Central well contains the rabbit-antiserum to rat liver
mitochondria. Surrounding wells contain various antigens as
illustrated below. HBM: AH130 bearing-rat liver mitochondria.
ABM: AH225A bearing-rat liver mitochondria. FBM: AH66F
bearing-rat liver mitochondria. YBM: Yoshida sarcoma bearing-
rat liver mitochondria. HMt: AH130 bearing-rat liver mito-
chondria. Fa: AH130 plasma membrane fraction.
(+l nomal rat liver mitochond (-
..-----.
anti~A.\ft seruO /
--------------'AMt
anti-NltM serunQ ""'"\
- -<::7> ..</~
nomal rat I iver mitochondria
'"t;~5]
AB.M
Fig. 15 The results of the immunoelectrophoresis.
The condition of electrophoresis in agar gel was in
260V, 20mA, at O°C, for 6 hours. After that, the
antigens were poured into the troughs at once, then
the Ouchterlony reaction was begun.
AMt : AH225A rat ascites hepatoma mitochondria.
ABM: AH225A rat ascites hepatoma bearing-rat liver
mitochondria.
The observations of tumor antitransplantability: Tumor antitransplan-
tability on the intraperitoneal transplantation of 2 X 107 fresh rat ascites
hepatoma cells was tested to the rats, weighing about 150 to 200 g im-
munized with cancer cell mitochondria. Twenty-seven rats out of the 50
immunized with cancer cell mitochondria (54 %) rejected the transplanta-
tion of ascites hepatoma and survived (Table 1). This suggests the presence
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Table I The tumor anti-transplantability of rat preimmunized with the
tumor mitochondria
57
immunized with
AH130 Mt
AH130 Nu
AH130 Mc
AH130 PI. Mem.
none
number of rats
50
5
7
6
50
number of survivals
27
2
o
o
o
%of anti-tumor-
transplantability
54
40
o
o
o
Each rat received three intraperitoneal injections, at once every week of 0.5 mg protein
of each antigen. The immunized rat was inoculated with AH 130 cells on the 14th day after
the last immunization. Control rats were not immunized. Mt: mitochondria. Nu: nuclei.
Mc: microsomes. PI. Mem.: plasma membrane.
of specific cancer antigenicity in cancer cell mitochondria. On the contra-
ry, in the intraperitoneal transplantation of 2 X 107 fresh ascites hepatoma
cells to the control groups, non-immunized or immunized with rat liver
mitochondria, and to the experimental groups immunized with the plasma
membrane fraction, the nuclear fraction, or the microsomal fraction of
rat ascites hepatoma cells, the tumor antitransplantability was not observed,
and these rats died on the 10th to the 14th day after the transplantation
of tumor cells. This indicates that the specific tumor antigenicity is remark-
ably present in the tumor cell mitochondria, but is not present in the
plasma membrane and the microsomes of tumor cells.
The effects of the antisera on the cancer cell mitochondrial ATP-ase activity :
The ATP·ase activity of sonicated AH130 rat ascites hepatoma cell mito-
chondria treated with the pooled antisera of rats showing the tumor-anti-
transplantability, was inhibited 38 %. The rabbit-antiserum to AH130 rat
ascites hepatoma cell mitochondria also inhibited the ATP-ase activity
29 %. On the contrary, the ATP·ase activity of sonicated rat liver mito-
Table 2 The effects of antisera on the ATPase activity of the sonicated hepatoma
cell mitochoedria. Activities are expressed as mf.' moles of released
Pi per mg of protein per minute at pH 7.6.
samples in the presence of antiserum ATP-ase activity 96 inhibition
sonicated none
297
rat-antiserum to AH130 mitochondria 183 38
AH130 cell
rabbit-antiserum to AH130 mitochondria 210 29
mitochondria
rabbit-antiserum to rat liver mitochondria 248 17
sonicated none 258
rat liver
mitochondria rabbit-antiserum to rat liver mitochondria 278 0
11
Wakabayashi: Immunological studies on the membrane systems of cancer cells
Produced by The Berkeley Electronic Press, 1969
58 A. WAKABAY ASHI
chondria treated with the rabbit-antiserum to the mitochondria was not
inhibited (Table 2).
The effects of the antisera on the respiratory activity of cancer cells: When
the AH 130 rat ascites hepatoma cells or its homogenate were treated with
the antisera to their own mitochondria, the oxygen consumption with
succinate as substrate was remarkably inhibited, comparing with that of
the non-treated AH 130 cells or its homogenate (Table 3).
Table 3 The effects of the antiserum on the respiratory activity of whole cell and
homogenate. The reaction mixture contained 0.05 M sucrose, 0.02 M KCl,
10 mM Tris-HCl (pH 7.4), O. 1 mM EDTA, I mM MgCl2, 3 mM sodium
succinate as a substrate, and whole cells or homogenate (total volume 2 mI).
Incubation was carried out by the addition of antiserum at 37°C, and
oxygen consumption was measured by a oxymeter with platinum electrode.
Activities are expressed as m,U moles 02 uptake per minute per mg of protein.
control antiserum to AHl30 mitochondria
whole cell 4.0
4.0
DISCUSSION
from rat
1.2
0.4
from rabbi-t--
0.4
o
Many immunological investigations of the irreversible transformations
of neoplasma have appeared with special reference to the specific cancer
antigenicities, using various immunochemical techniques such as the
immunodiffusion, immunoelectrophoresis, complement fixation, immuno.
fluorescence, and immunoferritin technique, etc.. As a result there arose
a question about the gain or loss of antigenicities at carcinogenic changes
of cells. ZILBER (6) reported the presence of the specific cancer antigenicity
in the hepatoma induced by chemical carcinogens. HIRAI (26) and others
(27-30) had stated that the new antigenicity was imparted to artificial
experimental neoplasma. RAPPORT and his collaborator (1954) (1) indicated
the possible existence of specific cancer antigen in the mitochondria of
rat lymphosarcoma; and HORN (1955) (2, 3), (1966) (4) reported the highest
antigenic fraction in Ehrlich ascites hepatoma cells to be detected in the
mitochondria and the nuclear fraction. TAKEDA and his collaborators
(1956) (5) stated that the rats immunized with the membrane fraction,
nuclear membrane, mitochondria, or insoluble parts of the nuclei of DAB
hepatoma acquired a strong anti-transplantability to this transplantable
hepatoma; KIKUCHI (1962) (7) reported similar results ; TAKAYANAGI (1964)
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(31) reported that several specific cancer antigens were found in (Xl to ri2
globulin regions in his immunochemical analysis of the extracted proteins
from DAB hepatomas; and HOKo (1966) (8) reported about the presence
of a specific cancer antigen in DOC insoluble fraction of cancer cell mito.
chondria. These reports suggest the definite existence of specific cancer
antigen. There are many other investigators who are of the opinions that
some antigenicities originally existing in normal organ, are diminished at
carcinogenic changes, resulting the simplification of antigenic components.
HOGEBOOM and his collaborator (1951) (32) reported that a part of protein
constituent disappeared at the carcinogenic transformation of cells in their
analyses of the cancer cell mitochondrial proteins; WEILER (9) also found
that the organ-specific antigens which originally existed in normal cells
disappeared in rat hepatomas; KAYE (12) antigenic changes in the anti.
genicities of urinary epithelial cells in the patients of urinary cancer; and
NAIRN (10, II) some of the organ.specific antigenicities to disappear in
the stomach or the intestine of the patients bearing cancer in digestive
organs; and BELOSHAPKINA (1967) (33) and others (13-16) reported the
data relating the loss of the organ-specific antigens in the organ of tumor·
bearing body.
In the present experiments, it is clear that the cancer mitochondria.
specific antigenicity reported previously (17) definitely exists in the four
different kinds of rat ascites tumors induced by chemical carcinogens and
that this specific antigenicity is common to those four tumors. These
results suggest that the specific cancer antigen is present in cancer cell
mitochondria. According to HORN'S reports (2-4) there exist the high
antigenicity in mitochondrial fraction of Ehrlich ascites hepatoma, and
by TAKEDA (5) and KIKUCHI (7) the rats immunized with TeA.treated
mitochondrial fraction of DAB hepatoma, acquire the tumor·antitrans-
plantability. However, it is possible that there may be some contamina·
tion in these fractions, because these fractions from cancer cells have not
been strictly fractionated in their experiments, and they did not report
on the fact that only the mitochondria had the strongest specific cancer
antigenicity in the membrane systems of cancer cells. As the mitochondria
in the present experiments have been strictly fractionated, it is thought
that the mitochondria are fully purified, and none of these investigators
have reported about the cancer mitochondria-specific antigenicity as can-
cer specific, but only HOKO (8) has suggested that there exists specific
cancer antigenicity in cancer cell mitochondria, which is absent in normal
cell mitochondria, similarly as in the present report. And it is reported
here that the cancer cell mitochondria. specific cancer antigenicity is
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situated immunoelectrophoretically in ,92 globulin position and this specific
cancer antigenicity of fJ2 globulin region is common to all the tumors cell
mitochondria. HOKO (8) does not refer to this respect, but there is a possi-
bility that one of the several specific cancer antigenicities in the extracted
proteins of DAB hepatoma as reported by TAKAYANAGI (31) lying in a 1 to
,92 globulin position immunoelectrophoretically, coincides with the cancer
mitochondria.specific cancer antigenicity reported here. It is firmly main-
tained here that this cancer mitochondria.specific cancer antigenicity is
common to all the tumors cell mitochondria of various kinds, but RAPPORT
et ai. (1), HORN (2-4), TAKEDA et ai. (5), ZILBER (6), KIKUCHI (7), and
HOKo (8), have not touched on this point. TAKEDA (5) and KIKUCHI (7)
asserted emphatically that on the contrary, there is no specific cancer
antigens common to all cancers induced by chemical carcinogens. BALDWIN
and his collaborator (34) investigated specific cancer antigens in various
cancers induced by chemical carcinogens and claimed that the specific
cancer antigen existed in individual tumors, and it was possible to produce
tumor resistance immunochemically to each tumor. However, they con-
tend that the specific tumor antigenicity of individual tumor is not com·
mon to each other, and there exists no antigenicity common to the tumors
induced by chemical carcinogens. Therefore, there are not so many reports
about the presence of specific cancer antigenicity common to all the tumors
except the present report. Only USUBUCHI and his collaborators (1967) (35)
have reported that there might exist common antigenicity among all the
malignant tumors in isogenuous mice, on the cross· immunization among
various tumors of C3H mouse, and DECKER and his collaborator (1966)
(36) recognized the existence of tumor specific antigens common to various
tumors of rat.
It is reported here that, when the rats are immunized with cancer
cell mitochondria, these rats acquire the tumor antitransplantability.
RAPPORT et ai. (l ), TAKEDA et ai. (5), AIGAWA et ai. (37), and KIKUCHI (7)
agree on this point, but their antitransplantability induced by tumor mito-
chondria was not so strong and remarkable as that reported here. It may
be pointed out that the biochemical investigations were made in the present
experiment to analyse by what mechanism the anti-transplantability to
tumor is acquired in an organism, while available reports do not deal with
this problem.
This mechanism may be explained as the resistance to transplantation
of cancer cells is imparted by the inhibitory effect of the antibody formed
in the recipients immunized with cancer cell mitochondria, resulting in
the inhibition of the mitochondrial ATP.ase and respiratory activities so
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that the cancer cells implanted can no longer proliferate.
By isolating and purifing the mitochondrial nucleic acids of various
tumors and analysing of their properties, it is possible to assume that the
cancer mitochondria-specific cancer antigen is found in cancer cell mito-
chondria if the cancer-specific DNA exists in cancer cell mitochondria,
and it follows then that the appearance of tumor resistance will take
place by immunization of cancer cell mitochondria in animals. On the
basis of these and referring to the appearance of the tumor-resistance in-
duced by viruses as reported by HABEL (38), SACKS (39), SJOEGREN (40),
and KOCH (41), this problem will be dealt with in part III, how the can·
cer mitochondria-specific cancer antigenicity would relate to virus-induced
tumors.
A discussion was made on the diminution of the original organ specific
antigenicities at carcinogenic changes of cells in the liver cell mitochondria,
and it was reported that the liver mitochondria-specific antigenicity of
tumor-bearing body exists in the liver mitochondria of animals bearing
tumor, which is not present in normal animal liver mitochondria. Con-
cerning the diminution or the disappearance of organ specific antigenicities
at carcinogenic transformation of cells in animals bearing tumor, there
are many reports by WEILER (9), who proved by immunofluorescent
technique that organ specific antigen of liver cell diminished in hepatoma
cell; by NAIRN et al. (11); KAYE et al (12); and NELKEN (13) who proved
that the organ specific antigenicities disappeared in animals bearing
tumor; and by DAO et at. (14); AMOS et at. (15); and HUR et al. (16) proved
that heterogenous skin graft was possible to the animals bearing tumor.
They reported the changes of antigenicities in animals bearing tumor, but
did not report the existence of tumor-bearing organ specific antigenicity
which did not exist ·in the same organ of normal animals. There are found
few reports dealing with antigenicities of both tumor and tumor-bearing
organs.
SUMMARY
As the results of investigating the antigenicities of various fractions
from the membrane systems of cancer cells, it has been found that the
remarkable cancer-specific antigenicity exists in cancer cell mitochondria.
With a particular reference to this antigenicity of cancer cell mitochon-
dria, the antigenicities of the mitochondria of various kinds of rat ascites
tumors and those of tumor-bearing rat liver mitochondria have been com-
pared with those of normal rat liver mitochondria. In addition, it has
15
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been demonstrated that a strong tumor antitransplantability is induced
when the recipient rat is immunized with the tumor cell mitochondria. In
order to support these experimental facts, enzymatic activities of cancer
cell mitochondria have been investigated also biochemically after treating
the mitochondria with the antiserum to these mitochondria.
1. The most remarkable cancer specific antigenicity exists in mito-
chondria among the membrane systems of cancer cells. This cancer mito-
chondria-specific cancer antigenicity is common to all the ascites tumor
mitochondria used here.
2. The original tissue- or organ-specific antigenicities diminish or
disappear at the carcinogenic transformation of cells.
3. The tumor-bearing-organ specific antigenicity appears in the
organs of animals bearing tumor.
4. The tumor antitransplantability is acquired when rats are immuni-
zed with these tumor cell mitochondria.
5. The inhibition of mitochondrial ATP·ase and respiratory activities
is observed when the cancer cell mitochondria are treated with the anti.
serum to the mitochondria.
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LEGENDS FOR PHOTOGRAPHS
The photographs are the results obtained by Ouchterlony double diffusion tests and
immunoelectrophoresis.
Photo. 1 Central well contains the rabbit-antiserum to AH130 rat ascites hepatoma mito-
chondria. Surrounding wells contain various antigens as illustrated below. HMt:
AH130 hepatoma mitochondria. AMt: AH225A hepatoma mitochondria. FMt:
AH66F hepatoma mitochondria. YMt: YOSHIDA sarcoma mitochondria. NRM:
rat liver mitochondria. HBM: AHl30 bearing-rat liver mitochondria.
Photo. 2 Central well contains the rabbit-antiserum to AH225A rat ascites hepatoma mito-
chondria. Surrounding wells contain various antigens as illustrated below. HMt:
AH130 hepatoma mitochondria. AMt: AH225A hepatoma mitochondria. FMt:
AH66F hepatoma mitochondria. YMt: Yoshida sarcoma mitochondria. N'RM:
rat liver mitochondria. ABM: AH225A bearing-rat liver mitochondria.
Photo. 3 The condition of electrophoresis in agar gel was in 260 V, 20 mA, at O°C, for 6
hours. After that, the antisera were poured into the troughs at once, then the
Ouchterlony reactions were begun. HMt: AH130 rat ascites hepatoma mitochon-
dria. AMt: AH225A rat ascites hepatoma mitochondria. NRM: rat liver mito-
chondrIa. FMt: AH66F rat ascites hepatoma mitochondria.
Photo. 4 Central well 'contains the rabbit-antiserum to AH225A hepatoma-bearing rat liver
mitochondria. Surrounding wells contain various antigens as illustrated below.
HBM: AHl30 hepatoma bearing-rat liver mitochondria. ABM: AH225A hepa-
toma bearing-rat liver mitochondria. FBM: AH66F hepatoma-bearing rat liver
mitochondria. YBM: YOSHIDA sarcoma bearing-rat liver mitochondria. NRM:
rat liver mitochondria. Mt: human liver mitochondria.
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Photo. 5 Central well contains the rabbit-antiserum to AH66F hepatoma bearing-rat liver
mitochondria. Surrounding wells contain various antigens as illustrated below.
HBM: AHl30 hepatoma bearing-rat liver mitochondria. ABM: AH225A hepa-
toma-bearing rat liver mitochondria. FBM: AH66F hepatoma bearing-rat liver
mitochondria. YBM: Yoshida sarcoma bearing-rat liver mitochondria. NRM:
rat liver mitochondria. Mt: human liver mitochondria.
Photo. 6 The condition of electrophoresis in agar gel was in 260 V, 20 mA, at O°C, for 6
hours. After that, the antisera were poured into the troughs at once, then the
Ouchterlony reactions were begun. NRM: rat liver mitochondria. ABM: AH225A
hepatoma bearing-rat liver mitochondria. FBM: AH66F hepatoma bearing-rat
liver mitochondria.
Photo. 7 Central well contains the rabbit antiserum to rat liver mitochondria. Surrounding
wells contain various antigens as illustrated below. HMt: AH130 rat ascites
hepatoma mitochondria. AMt: AH225A rat ascites hepatoma mitochondria. FMt:
AH66F rat ascites hepatoma mitochondria. YMt: Yoshida sarcoma mitochondria.
NMT: rat liver mitochondria. Fz: rat liver microsomes.
Photo. 8 Central well contains the rabbit-anti-AHI30 cell mitochondria serum absorbed
with rat liver mitochondria. Surrounding wells contain various antigens as illu-
strated below. HMt: AH130 rat ascites hepatoma mitochondria. AMt: AH225A
rat ascites hepatoma mitochondria. FMt: AH66F rat ascites hepatoma mitochon-
dria. YMt: Yoshida sarcoma mitochondria. NRM: rat liver mitochondria. ABM:
AH225A hepatoma bearing-rat liver mitochondria.
Photo. 9 Central well contains the rabbit-antiserum to rat liver mitochondria. Surrounding
wells contain various antigens as illustrated below. HBM: AH 130 hepatoma
bearing-rat liver mitochondria. ABM: AH225A hepatoma bearing-rat liver mito-
chondria. FBM: AH66F hepatoma-bearing rat liver mitochondria. YBM: Yoshida
sarcoma bearing-rat liver mitochondria. HMt: AH130 rat ascites hepatoma mito-
chondria. Fo: AH130 plasma membrane fraction.
Photo.1O The condition of electrophoresis in agar gel was in 260 V, 20 mA, at O°C, for
6 hours. After that, the antigens were poured into the tronghs at once, then the
Ouchterlony reactions were begun. AMt: AH225A rat ascites hepatoma mito-
chondria. ABM: AH225A hepatoma bearing-rat liver mitochondria.
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